Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Treatment of Breast Yeast Infections

Diagnosis

  • The diagnosis of breast candidiasis can be confirmed by visualization of yeast or pseudohyphae in wet preparations with 10% KOH or positive culture for yeast species, according to Praxis Medical Insights 1

Treatment Options

  • Breast yeast infections should be treated with topical azole antifungals or oral fluconazole, with both options providing effective relief in 80-90% of uncomplicated cases, as recommended by Praxis Medical Insights 1
  • First-line therapy includes topical azole antifungals applied to the nipple/areola area, such as clotrimazole 1% cream or miconazole 2% cream, as suggested by Praxis Medical Insights 1
  • Fluconazole 150 mg as a single dose is recommended for uncomplicated cases, according to Praxis Medical Insights 1

Treatment Algorithm

  • For mild to moderate cases, begin with topical azole antifungal (clotrimazole 1% or miconazole 2%) applied to nipples after each feeding, and continue treatment for 7-14 days, as recommended by Praxis Medical Insights 1 and MMWR Recommendations and Reports 2

Important Considerations

  • Topical azole creams should be wiped off before breastfeeding if applied shortly before, as advised by Praxis Medical Insights 1
  • Oil-based creams and suppositories may weaken latex condoms and diaphragms, according to MMWR Recommendations and Reports 2

Follow-Up

  • Patients should return for follow-up only if symptoms persist after completing treatment or if symptoms recur, as recommended by Praxis Medical Insights 1

Common Pitfalls

  • Premature discontinuation of therapy can lead to treatment failure, and it is recommended to complete the full course even if symptoms improve, as advised by Praxis Medical Insights 1

REFERENCES

1

Treatment of Vaginal Candidiasis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025